1-year results of combined half-dose photodynamic therapy and ranibizumab for polypoidal choroidal vasculopathy

被引：0
|
作者：
Ian Y. Wong
Xuan Shi
Rita Gangwani
Paul Zhao
Lawrence P. Iu
Qing Li
Alex Ng
Xiaoxin Li
机构：
[1] The University of Hong Kong,Department of Ophthalmology, LKS Faculty of Medicine
[2] Peking University People’s Hospital,Department of Ophthalmology
[3] National University Hospital,Department of Ophthalmology
来源：
BMC Ophthalmology | / 15卷
关键词：
Age related macular degeneration; Half-dose; Half-fluence; Photodynamic therapy; Polypoidal choroidal vasculopathy; Ranibizumab; Verteporfin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] 1-year results of combined half-dose photodynamic therapy and ranibizumab for polypoidal choroidal vasculopathy
    Wong, Ian Y.
    Shi, Xuan
    Gangwani, Rita
    Zhao, Paul
    Iu, Lawrence P.
    Li, Qing
    Ng, Alex
    Li, Xiaoxin
    BMC OPHTHALMOLOGY, 2015, 15
  • [2] Half-dose photodynamic therapy alone or combined with ranibizumab in Polypoidal Choroidal Vasculopathy
    Frascio, Pietro
    Nicolo, Massimo
    Rosa, Raffaella
    Musolino, Maria
    Traverso, Carlo Enrico
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
  • [3] HALF-DOSE PHOTODYNAMIC THERAPY COMBINED WITH BEVACIZUMAB FOR POLYPOIDAL CHOROIDAL VASCULOPATHY
    Lee, Jae Hyung
    Lee, Won Ki
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2015, 35 (08): : 1561 - 1568
  • [4] Half-Dose Photodynamic Therapy Combined with Bevacizumab for Polypoidal Choroidal Vasculopathy
    Lee, Jae Hyung
    Lee, Mee Yon
    Lee, Won Ki
    OPHTHALMOLOGICA, 2014, 232 : 5 - 5
  • [5] Photodynamic therapy combined with ranibizumab for polypoidal choroidal vasculopathy: results of a 1-year preliminary study
    Ruamviboonsuk, P.
    Tadarati, M.
    Vanichvaranont, S.
    Hanutsaha, P.
    Pokawattana, N.
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2010, 94 (08) : 1045 - 1051
  • [6] ONE-YEAR RESULTS OF HALF- VERSUS STANDARD-DOSE PHOTODYNAMIC THERAPY COMBINED WITH RANIBIZUMAB FOR POLYPOIDAL CHOROIDAL VASCULOPATHY
    Wong, Ian Y.
    Shi, Xuan
    Gangwani, Rita
    Iu, Lawrence P.
    Fung, Nicholas
    Li, Qing
    Ng, Alex L. K.
    Li, Xiaoxin
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2018, 38 (04): : 725 - 730
  • [7] Two-year results of combined intravitreal ranibizumab and photodynamic therapy for polypoidal choroidal vasculopathy
    Saito, Masaaki
    Iida, Tomohiro
    Kano, Mariko
    Itagaki, Kanako
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2013, 251 (09) : 2099 - 2110
  • [8] Two-year results of combined intravitreal ranibizumab and photodynamic therapy for polypoidal choroidal vasculopathy
    Masaaki Saito
    Tomohiro Iida
    Mariko Kano
    Kanako Itagaki
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2013, 251 : 2099 - 2110
  • [9] COMBINED INTRAVITREAL RANIBIZUMAB AND PHOTODYNAMIC THERAPY FOR POLYPOIDAL CHOROIDAL VASCULOPATHY
    Saito, Masaaki
    Iida, Tomohiro
    Kano, Mariko
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2012, 32 (07): : 1272 - 1279
  • [10] PHOTODYNAMIC THERAPY, RANIBIZUMAB, AND RANIBIZUMAB WITH PHOTODYNAMIC THERAPY FOR THE TREATMENT OF POLYPOIDAL CHOROIDAL VASCULOPATHY
    Rouvas, Alexandros A.
    Papakostas, Thanos D.
    Ntouraki, Amalia
    Douvali, Maria
    Vergados, Ioannis
    Ladas, Ioannis D.
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2011, 31 (03): : 464 - 474
12345